Tags

Type your tag names separated by a space and hit enter

Global incidence of carbapenemase-producing Escherichia coli ST131.
Emerg Infect Dis. 2014 Nov; 20(11):1928-31.EI

Abstract

We characterized Escherichia coli ST131 isolates among 116 carbapenemase-producing strains. Of isolates from 16 countries collected during 2008-2013, 35% belonged to ST131 and were associated with blaKPC, H30 lineage, and virotype C. This study documents worldwide incidents of resistance to "last resort" antimicrobial drugs among a common pathogen in a successful sequence type.

Links

PMC Free PDF

Authors

Peirano G
No affiliation info available
Bradford PA
No affiliation info available
Kazmierczak KM
No affiliation info available
Badal RE
No affiliation info available
Hackel M
No affiliation info available
Hoban DJ
No affiliation info available
Pitout JD
No affiliation info available

MeSH

Anti-Bacterial AgentsBacterial ProteinsEscherichia coliEscherichia coli InfectionsGlobal HealthHumansIncidenceMicrobial Sensitivity Testsbeta-Lactam Resistancebeta-Lactamases

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25340464

Citation

Peirano, Gisele, et al. "Global Incidence of Carbapenemase-producing Escherichia Coli ST131." Emerging Infectious Diseases, vol. 20, no. 11, 2014, pp. 1928-31.
Peirano G, Bradford PA, Kazmierczak KM, et al. Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis. 2014;20(11):1928-31.
Peirano, G., Bradford, P. A., Kazmierczak, K. M., Badal, R. E., Hackel, M., Hoban, D. J., & Pitout, J. D. (2014). Global incidence of carbapenemase-producing Escherichia coli ST131. Emerging Infectious Diseases, 20(11), 1928-31. https://doi.org/10.3201/eid2011.141388
Peirano G, et al. Global Incidence of Carbapenemase-producing Escherichia Coli ST131. Emerg Infect Dis. 2014;20(11):1928-31. PubMed PMID: 25340464.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Global incidence of carbapenemase-producing Escherichia coli ST131. AU - Peirano,Gisele, AU - Bradford,Patricia A, AU - Kazmierczak,Krystyna M, AU - Badal,Robert E, AU - Hackel,Meredith, AU - Hoban,Daryl J, AU - Pitout,Johann D D, PY - 2014/10/24/entrez PY - 2014/10/24/pubmed PY - 2015/6/25/medline SP - 1928 EP - 31 JF - Emerging infectious diseases JO - Emerg Infect Dis VL - 20 IS - 11 N2 - We characterized Escherichia coli ST131 isolates among 116 carbapenemase-producing strains. Of isolates from 16 countries collected during 2008-2013, 35% belonged to ST131 and were associated with blaKPC, H30 lineage, and virotype C. This study documents worldwide incidents of resistance to "last resort" antimicrobial drugs among a common pathogen in a successful sequence type. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/25340464/full_citation DB - PRIME DP - Unbound Medicine ER -